MOTION Vienna

Clinical Research Group MOTION @MedUniWien
funded by @LBG_research
Focusing on disease-driving mechanisms in patients with #PortalHypertension
#LiverFibrosis

[MOTION Vienna @CrgMotion]

👋Project MOTION says goodbye to X 👋
Thanks to everyone who followed, liked, shared & supported our journey.

⚡️Stay tuned on our research, clinical studies & team insights on LinkedIn and Bluesky.➡️
#ProjectMotion #THX #SigningOff

[MOTION Vienna @CrgMotion]

@LorenzBalcar newest publicatioN:
In BCR::ABL1⁻ MPN, spleen stiffness measurement (SSM) via transient elastography offers a non-invasive way to detect & stratify #portalhypertension - independently of liver stiffness.
A promising tool to improve risk assessment & management
📊👇

[MOTION Vienna @CrgMotion]

New paper by @LorenzBalcar shows that #spleenstiffness measurement (SSM) via transient elastography helps non-invasively stratify #portalhypertension in BCR::ABL1⁻ MPN — beyond #liver stiffness.

A step forward in risk assessment!
📊👇More info 📊👇 https://t.co/CkgkwhfwnV

[MOTION Vienna @CrgMotion]

Some of our Motion team members are currently at #EASL2025 in Amsterdam — proudly representing our deep expertise in liver research and innovation. Come say hi if you're around! 👋

#MotionTeam #EASL2025 #LiverResearch #Innovation #ProudToRepresent

[Thomas Reiberger @ReibergerThomas]

@ViennaLiverNews @MedUni_Wien @EASLnews Congress #2025 in #Amsterdam

[MOTION Vienna @CrgMotion]

#Portalhypertension Fans

🥂🥂 OUR deputy PI @MattiasMandorf1.
received the "EASL Emerging Leader Awards 2025" in Amsterdam yesterday at #EALS2025

We congratulate him from the bottom of our #livers �� and are incredibly proud!

[Mattias Mandorfer @MattiasMandorf1]

Thirteen years ago when I was still an M.D. student, I was invited for my first oral presentation at an @EASLnews event.
🙏 to @EASLedu for inspiration, education & support throughout this journey as well as to my mentors & friends! @BavenoCoop #LiverTwitter

[MOTION Vienna @CrgMotion]

#LiverScience #BasicResearch #PortalHypertension
🔬 WP8🔬 Decoding the Vascular Niche in Liver Disease
WP8 dives into the biology of angiogenesis in cirrhosis & PH.
🧫 SingleCell RNA sequencing of endothelial cells
🧬 Multiplexed histology
💉 Angiogenic cytokines
📷More info📷⬇️

[MOTION Vienna @CrgMotion]

#xliver #portalhypertension #clinicaltrail #radomics Fans
Introducing work package nr. 7 which is about radiology.

🌐More info in the video below 📷 📷📷📷⬇️⬇️⬇️

[MOTION Vienna @CrgMotion]

🌐Fridays with the MOTION Team = science, smiles & serious vibes ���🧪
Just something else.... :) 🌐

When top-notch research meets good energy, magic happens. Work hard, laugh harder — that’s how we roll.

#MOTIONProject #ScienceSquad #FridayFeeling #TeamworkMakesTheDreamWork

[Thomas Reiberger @ReibergerThomas]

Casual #LiverTeam Friday @MedUni_Wien
featuring 🐠#Trapezfisch #AKHMensa

[MOTION Vienna @CrgMotion]

#portalHypertension & #Radiomics Fans 🙌
Introducing WP7: Focusing on radiomics.
The team develops imaging-based diagnostic & staging tools for #PH.

🌐More info in the graphic below 🌐
⬇️⬇️⬇️⬇️

[MOTION Vienna @CrgMotion]

#Portalhypertension #coagulation #xliver #Clinicaltrial
🩸Next - WP6: Coagulation & Hemostasis Research

Our specialists is working to characterize rebalanced hemostasis in #ACLD & #PSVD using advanced diagnostics like #ClotPro & TM-TGA.

[MOTION Vienna @CrgMotion]

#portalHypertension #clinicaltrail
ONE YEAR ago we started with the online presence of the MOTION project and so much has happened during the last 365 day!

🩸AND THERE IS MORE TO COME🩸

⬇️STAY TUNED ⬇️
#MyXAnniversary

[MOTION Vienna @CrgMotion]

#xliver #portalhypertension #clinicaltrail
Our next WP5 introduced and led by @mathiasjachs 🖐️
Developing prognostic #NIT models for #ACLD or #PSVD
📷More info in the video below 📷

[MOTION Vienna @CrgMotion]

"#twitterliver 👋#PortalHypertension Fans !!
Introducing MOTION WP 4 by @MattiasMandorf1 - Comparing #HVPG responses of our medication within our clinical trials to NSBBS...
🌐More info in the video below 📷🔽

[MOTION Vienna @CrgMotion]

🥂Congrats🥂
Amazing achievement by our WP2 Co-Leader, Dr. Benedikt Simbrunner #MD #PhD!

[Thomas Reiberger @ReibergerThomas]

Dr. Benedikt Simbrunner #MD #PhD of @MedUni_Wien received yesterday a very special honor:

🎓Promotio sub auspiciis Praesidentis rei publicae

🇦🇹#PhD Promotion with best possible grades throughout the career 🔗https://t.co/iKw24DSduQ

[MOTION Vienna @CrgMotion]

#twitterliver #xliver#NIT #HVPG #ClinicalTrial #ACLD #PSVD #PortalHypertension Fans !! 👏👋

Introducing MOTION WP 4 & 5 focusing on #HVPG responses & NIT models....

📷More info in the graphic 📷

[MOTION Vienna @CrgMotion]

🧬 New Study Alert! 🧬
Groundbreaking research by @ReibergerThomas, @hartl_md & colleagues reveals that decreasing IL-6 levels after #TIPS implantation can predict better outcomes in decompensated cirrhosis.
#LiverHealth #Cirrhosis #MedicalResearch #TIPS #inflammation

[MOTION Vienna @CrgMotion]

#xliver #PortalHypertension #ClinicalTrials FANs! 👋
Introducing the next work-package focusing on patients with porto-sinusoidal vascular disorder. #PSVD
🌐More info in the video below 🔽

[MOTION Vienna @CrgMotion]

#twitterliver #xliver👋#PortalHypertension Fans !! MOTION WP 3 - Focusing on PSVD 📷More info in the graphic 📷⬇️

[MOTION Vienna @CrgMotion]

#liverx #twitterliver 👋#PortalHypertension Fans !!
Introducing MOTION WP 2 by @ReibergerThomas - Focusing on decompensated cirrhosis..
🌐More info in the video below 📷🔽

[MOTION Vienna @CrgMotion]

"#twitterliver 👋#PortalHypertension Fans !!
TODAY, we had the incredible opportunity to make a descriptive video about our MOTION Project — shedding light on this groundbreaking clinical trial....

Excited to share more soon—stay tuned! 🚀